Open AccessHarnessing the Natural Toxic Metabolites in COVID-19
Author(s) -
Ali Mohammad Bahrami,
Mohammad Taheri,
Mohammad Reza Arabestani,
Meysam Soleimani,
Mojdeh Mohammadi,
Fatemeh Noushin Golabchi,
Maryam Banitorfi,
Seyed Mostafa Hosseini,
Sodabe Khodabandehlou,
Fatemeh Nouri
Publication year - 2022
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2022/3954944
Subject(s) - sore throat , medicine , covid-19 , pandemic , coronavirus , ards , disease , immunology , intensive care medicine , virology , lung , infectious disease (medical specialty) , outbreak
SARS-CoV-2 is a novel coronavirus and the cause of the recent pandemic; it is an enveloped β-coronavirus. SARS-CoV-2 appear in the Wuhan City of China for the first time and outspread worldwide quickly. Due to its person-to-person fast transmission, COVID-19 is becoming a global problem. SARS-CoV-2 enter into cells by using ACE2 receptors that are numerous in the lungs and finally can cause acute respiratory distress syndrome (ARDS). Dry cough, sore throat, fever, body pain, headache, GIT discomfort, diarrhoea, and fatigue are some of the COVID-19 symptoms. There is no definite and certain treatment for disease caused by SARS-CoV-2 till now. Some pharmacological effects of toxins, toxoids, and venoms have been proven, and their effects on some diseases have been evaluated. This study aimed to investigate the role of toxins, toxoids, and venom in the pathophysiology of COVID-19 disease.